Skip to main content

Peer Review reports

From: Cost-utility analysis of esketamine and electroconvulsive therapy in adults with treatment-resistant depression

Original Submission
27 Jun 2021 Submitted Original manuscript
21 Jul 2021 Reviewed Reviewer Report
17 Sep 2021 Reviewed Reviewer Report
8 Oct 2021 Author responded Author comments - Fredrik Norström
12 Oct 2021 Author responded Author comments - Fredrik Norström
Resubmission - Version 2
8 Oct 2021 Submitted Manuscript version 2
13 Oct 2021 Author responded Author comments - Fredrik Norström
Resubmission - Version 3
13 Oct 2021 Submitted Manuscript version 3
14 Oct 2021 Reviewed Reviewer Report
24 Oct 2021 Reviewed Reviewer Report
3 Nov 2021 Author responded Author comments - Fredrik Norström
Resubmission - Version 4
3 Nov 2021 Submitted Manuscript version 4
Publishing
11 Nov 2021 Editorially accepted
7 Dec 2021 Article published 10.1186/s12888-021-03601-8

You can find further information about peer review here.

Back to article page